Published in Eur J Gastroenterol Hepatol on February 01, 2014
Increased risk for irritable bowel syndrome after acute diverticulitis. Clin Gastroenterol Hepatol (2013) 4.24
Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med (2010) 3.74
The economic burden of diabetes. Health Aff (Millwood) (2010) 3.19
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry (2012) 2.14
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. Appl Health Econ Health Policy (2012) 2.06
Regional deposition of mometasone furoate nasal spray suspension in humans. Allergy Asthma Proc (2015) 2.04
Zoonosis emergence linked to agricultural intensification and environmental change. Proc Natl Acad Sci U S A (2013) 1.74
The economic value of professional nursing. Med Care (2009) 1.74
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr (2012) 1.73
A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med (2012) 1.67
MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J Leukoc Biol (2010) 1.62
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs (2013) 1.58
Patient-centered decision making and health care outcomes: an observational study. Ann Intern Med (2013) 1.40
Spatial analysis of sleeping sickness, southeastern Uganda, 1970-2003. Emerg Infect Dis (2006) 1.39
Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol (2013) 1.35
Exercise in pregnancy and the postpartum period. J Obstet Gynaecol Can (2003) 1.33
Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE prime-enrolled population. Am J Health Promot (2007) 1.30
Using remote sensing and geographic information systems to identify villages at high risk for rhodesiense sleeping sickness in Uganda. Trans R Soc Trop Med Hyg (2005) 1.18
Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord (2012) 1.17
Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc (2009) 1.16
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry (2013) 1.03
Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther (2012) 1.01
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes (2012) 1.01
Cattle owners' perceptions of African bovine trypanosomiasis and its control in Busia and Kwale Districts of Kenya. Acta Trop (2003) 0.99
Sleeping sickness in Uganda: revisiting current and historical distributions. Afr Health Sci (2006) 0.99
Health care reform in six Central European countries. A focus on health economic requirements in the drug pricing and reimbursement processes. Eur J Health Econ (2003) 0.97
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. J Infect Dis (2012) 0.95
Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease. Mol Ther (2013) 0.95
Evaluation of airway blocks versus general anaesthesia for diagnostic direct laryngoscopy and biopsy for carcinoma larynx. J Indian Med Assoc (2012) 0.95
Health care use and costs for participants in a diabetes disease management program, United States, 2007-2008. Prev Chronic Dis (2011) 0.94
Uncharted territory: measuring costs of diagnostic errors outside the medical record. BMJ Qual Saf (2012) 0.94
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin (2010) 0.93
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry (2012) 0.93
Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol (2008) 0.92
The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician's point of view. Eur Child Adolesc Psychiatry (2011) 0.92
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient (2011) 0.90
Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study. BMC Health Serv Res (2013) 0.89
Application of field methods to assess isometamidium resistance of trypanosomes in cattle in western Ethiopia. Acta Trop (2004) 0.89
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review. CNS Drugs (2012) 0.89
ADHD burden of illness in older adults: a life course perspective. Qual Life Res (2011) 0.89
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? Child Adolesc Psychiatry Ment Health (2009) 0.88
Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord (2012) 0.87
Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system. J Child Adolesc Psychopharmacol (2010) 0.87
Cost effectiveness of lenalidomide in the treatment of transfusion-dependent myelodysplastic syndromes in the United States. Cancer Control (2006) 0.87
A clinical study comparing epinephrine 200μg or clonidine 90μg as adjuvants to local anaesthetic agent in brachial plexus block via supraclavicular approach. J Anaesthesiol Clin Pharmacol (2010) 0.87
Occupational issues of adults with ADHD. BMC Psychiatry (2013) 0.87
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs (2013) 0.86
Trypanocidal failure suggested by PCR results in cattle field samples. Acta Trop (2004) 0.86
An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr (2005) 0.86
Adult ADHD: prevalence of diagnosis in a US population with employer health insurance. Curr Med Res Opin (2011) 0.86
A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective. J Med Econ (2010) 0.85
Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants. J Antimicrob Chemother (2011) 0.85
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis. J Med Econ (2013) 0.84
Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment. Patient (2012) 0.84
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative research. Patient (2015) 0.84
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value Health (2011) 0.84
Association between Sleep Disruption and Levels of Lipids in Caucasians with Type 2 Diabetes. Int J Endocrinol (2013) 0.84
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications. J Med Econ (2013) 0.84
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD. J Atten Disord (2007) 0.83
Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health Qual Life Outcomes (2013) 0.83
SAPs as novel regulators of abiotic stress response in plants. Bioessays (2013) 0.82
Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy. Thyroid (2013) 0.82
Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences. Int J Technol Assess Health Care (2011) 0.82
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol (2012) 0.82
The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis (2014) 0.82
Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder. Drugs R D (2013) 0.82
Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries. Eur Child Adolesc Psychiatry (2014) 0.81
HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. Curr Med Res Opin (2009) 0.81
Preparing veterinarians for work in resource-poor settings. J Am Vet Med Assoc (2013) 0.81
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterol (2013) 0.81
Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Qual Life Res (2014) 0.81
Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway. J Cell Physiol (2015) 0.80
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. Pharmacoeconomics (2012) 0.80
Executive function and diabetes mellitus--a stone left unturned? Curr Diabetes Rev (2012) 0.80
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. J Manag Care Pharm (2012) 0.79
DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene. Inorg Chem (2013) 0.79
Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis. Inflamm Bowel Dis (2013) 0.79
Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine. BMC Health Serv Res (2011) 0.79
Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity. J Med Econ (2012) 0.79
Content coding for contextualization of care: evaluating physician performance at patient-centered decision making. Med Decis Making (2013) 0.79
Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults. J Med Econ (2013) 0.78
Unannounced standardized patient assessment of the roter interaction analysis system: the challenge of measuring patient-centered communication. J Gen Intern Med (2012) 0.78
8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice. Mol Cell Endocrinol (2010) 0.78
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany. Clin Ther (2013) 0.78
DNA/protein binding, molecular docking, and in vitro anticancer activity of some thioether-dipyrrinato complexes. Inorg Chem (2013) 0.78
Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation. Eur J Gastroenterol Hepatol (2014) 0.77
Automated identification of patients with a diagnosis of binge eating disorder from narrative electronic health records. J Am Med Inform Assoc (2013) 0.77
Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder. Am J Manag Care (2014) 0.77
Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009. J Child Adolesc Psychopharmacol (2014) 0.77
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine. Qual Life Res (2014) 0.76
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care population. Curr Med Res Opin (2014) 0.76